31 results
10-K
2023 FY
EX-10.22
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
to be in compliance therewith. If Executive notifies the Company that Executive has received advice of tax counsel of a national reputation with expertise
10-K
2023 FY
EX-10.23
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
of tax counsel of a national reputation with expertise in Section 409A that any provision of this Agreement would cause Executive to incur any
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
, could damage our reputation and business.
Table of Contents
ITEM 1A. Risk Factors.
RISK FACTORS
Investing in shares of our common stock involves … to be immaterial, could materially and adversely affect our business, financial condition, reputation, or results of operations. In such case, the trading
S-8
EX-99.3
NMRA
Neumora Therapeutics Inc.
19 Sep 23
Registration of securities for employees
9:57pm
or will have a material detrimental effect on the Company’s reputation or business; (c) the Participant’s gross misconduct; (d) the Participant’s willful
424B4
qvk xs62bvjzz2
18 Sep 23
Prospectus supplement with pricing info
4:12pm
S-1/A
zpfszbt2i7nsl3u52449
11 Sep 23
IPO registration (amended)
6:07am
S-1
EX-10.11
zn30g q44u86
25 Aug 23
IPO registration
5:03pm
S-1
zznouatxfvv61tdw90m
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.15
7ymtunuifao6lhof hzl
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.7
1061ds4oylj
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.9
4vl5lf41ow0gp4ycb4ka
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.10
3f9wikejvmzhv3ko
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.16
otyx4lp
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.20
azxby88
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.5
zsj lypaclvoigb5g9z
25 Aug 23
IPO registration
5:03pm
DRS/A
hivdt2b
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
EX-10.21
4zwctjyl2x vq79xx
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
fe9y6 q3d623n9v9
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
EX-10.10
dnqbkoxhr7ez6gv
30 Jun 23
Draft registration statement (amended)
12:00am